EN
DE
Home>Research>Research Groups>Morrison>Publications

Morrison Research Group

Publications

2016

  • Growth factor and co-receptor release by structural regulation of substrate metalloprotease accessibility.
    Parra* LM, Hartmann* M, Schubach S, Ma J, Herrlich** P, Herrlich** A
    Sci Rep 2016, 6, 37464 * equal contribution, ** co-senior authors
  • Ezrin functions in brain development and disease
    Riecken LB
    Dissertation 2016, Jena, Germany
  • CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins.
    Riecken LB, Zoch A, Wiehl U, Reichert S, Scholl I, Cui Y, Ziemer M, Anderegg U, Hagel C, Morrison H
    Oncotarget 2016, 7(48), 78242-54
  • Function of the tumour suppressor protein merlin in neurons of the central nervous system
    Rübsam J
    Dissertation 2016, Jena, Germany
  • The importance of nerve microenvironment for schwannoma development.
    Schulz A, Büttner R, Hagel C, Baader SL, Kluwe L, Salamon J, Mautner VF, Mindos T, Parkinson DB, Gehlhausen JR, Clapp DW, Morrison H
    Acta Neuropathol 2016, 132(2), 289-307
  • Neuron-Specific Deletion of the Nf2 Tumor Suppressor Impairs Functional Nerve Regeneration.
    Schulz A, Büttner R, Toledo A, Baader SL, von Maltzahn J, Irintchev A, Bauer R, Morrison H
    PLoS One 2016, 11(7), e0159718
  • Genetic Factors of the Disease Course After Sepsis: Rare Deleterious Variants Are Predictive.
    Taudien* S, Lausser* L, Giamarellos-Bourboulis EJ, Sponholz C, Schöneweck F, Felder M, Schirra LR, Schmid F, Gogos C, Groth S, Petersen BS, Franke A, Lieb W, Huse K, Zipfel PF, Kurzai O, Moepps B, Gierschik P, Bauer M, Scherag A, Kestler** HA, Platzer** M
    EBioMedicine 2016, 12, 227-38 * equal contribution, ** co-senior authors
  • Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.
    Yao YH, Cui Y, Qiu XN, Zhang LZ, Zhang W, Li H, Yu JM
    Chin J Cancer 2016, 35(1), 50

2015

  • Inside-out Regulation of Ectodomain Cleavage of Cluster-of-Differentiation-44 [CD44] and of Neuregulin-1 requires Substrate Dimerization.
    Hartmann M, Parra LM, Ruschel A, Lindner C, Morrison H, Herrlich** A, Herrlich** P
    J Biol Chem 2015, 290(28), 17041-54 ** co-senior authors, 2015 Best of jbc Papers of the Week Winner
  • Tumor suppressor NF2 blocks cellular migration by inhibiting ectodomain cleavage of CD44.
    Hartmann* M, Parra* LM, Ruschel A, Schubert S, Li Y, Morrison H, Herrlich** A, Herrlich** P
    Mol Cancer Res 2015, 13(5), 879-90 * equal contribution, ** co-senior authors